160 related articles for article (PubMed ID: 2068687)
1. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
[TBL] [Abstract][Full Text] [Related]
2. [Effect of kavinton on the hemodynamics and adenosine metabolism in atherosclerosis patients].
Mikunis RI; Serkova VK; Zhebel' VN
Vrach Delo; 1988 Jul; (7):27-9. PubMed ID: 3188457
[No Abstract] [Full Text] [Related]
3. [Disorders in lipoprotein metabolism indices in cerebral atherosclerosis, their importance for diagnosis and medical-occupational expertise].
Mitsenko MD; Mikhaĭliuk IA; Kukhtevich II
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(7):998-1003. PubMed ID: 197759
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
Rugginenti
Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
[No Abstract] [Full Text] [Related]
5. [Specifics of lipid exchange in patients with atherosclerotic lesions of the coronary and cerebral arteries].
Korneva VA
Klin Med (Mosk); 2005; 83(2):44-7. PubMed ID: 15803832
[TBL] [Abstract][Full Text] [Related]
6. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
Kostner GM; Marth E; Pfeiffer KH; Wege H
Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
[No Abstract] [Full Text] [Related]
7. [Changes of blood lipid fractions produced by phosphatidyl choline in patients with atherosclerosis].
Caruzzo C; Enrico-Bena L; Carnaghi R
Minerva Med; 1969 Apr; 60(34):1643-52. PubMed ID: 5770941
[No Abstract] [Full Text] [Related]
8. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
Notarbartolo A; Di Fede G; Cupidi G; Rini GB
Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
[No Abstract] [Full Text] [Related]
9. [Correction of biochemical disorders in the lipid metabolism of atherosclerosis patients by using the antioxidant dibunol].
Barsel' VA; Korochkin IM; Arkhipova GV; Sal'nikov MI; Matveeva SA
Izv Akad Nauk SSSR Biol; 1988; (1):75-85. PubMed ID: 3351102
[No Abstract] [Full Text] [Related]
10. [Optimization of the loading in therapeutic physical exercise for patients with initial cerebral atherosclerosis].
Sokolova LD
Vopr Kurortol Fizioter Lech Fiz Kult; 1989; (1):56-9. PubMed ID: 2711640
[TBL] [Abstract][Full Text] [Related]
11. [Lipid free-radical oxidation in cerebral arteriosclerosis patients in relation to the stage of the disease].
Bobyreva LE; Del'va VA; Samarchenko LA; Bobyrev VN; Voskresenskiĭ ON
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1309-12. PubMed ID: 3425071
[TBL] [Abstract][Full Text] [Related]
12. The role of plasma lipids in carotid bifurcation atherosclerosis.
Ford CS; Crouse JR; Howard G; Toole JF; Ball MR; Frye J
Ann Neurol; 1985 Mar; 17(3):301-3. PubMed ID: 3994317
[TBL] [Abstract][Full Text] [Related]
13. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
Bompani R; Violi G
Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
[No Abstract] [Full Text] [Related]
14. [Triglyceride-rich lipoproteins as risk factors for atherosclerosis].
Schwandt P
Klin Wochenschr; 1990; 68 Suppl 22():54-8. PubMed ID: 2087080
[TBL] [Abstract][Full Text] [Related]
15. [Atherosclerosis of the major arteries of the head and the content of lipoprotein(a) in the blood plasma].
Varakin IuIa; Oshchepkova EV; Skvortsov AV; Adamova IIu; Dzhibladze DN; Arabidze GG; Pokrovskiĭ SN
Ter Arkh; 1993; 65(3):54-6. PubMed ID: 8059386
[TBL] [Abstract][Full Text] [Related]
16. [Effect of sulfocamphocaine on the systemic and cerebral hemodynamics of patients with chronic cerebral circulatory failure].
Ishchenko MM; Shkrobot SI
Vrach Delo; 1984 Jul; (7):68-70. PubMed ID: 6475025
[No Abstract] [Full Text] [Related]
17. [The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia].
Iurenev AP; Zhukova IM; Lediashova GA; Kiseleva OA; Pomerantsev EV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):71-4. PubMed ID: 2604892
[TBL] [Abstract][Full Text] [Related]
18. [Piracetam and the indicators of cerebral hemodynamics, lipid metabolism and rheological properties of blood in the initial forms of cerebrovascular disorders].
Eninia GI; Timofeeva TN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(11):20-3. PubMed ID: 1963971
[TBL] [Abstract][Full Text] [Related]
19. [Regression of coronary arteriosclerosis by treatment of disorders of lipid metabolism? Initial clinical results and methodologic problems].
von Essen R
Internist (Berl); 1992 Jan; 33(1):62-6. PubMed ID: 1551764
[No Abstract] [Full Text] [Related]
20. Comparison of HLA antigen spectrum in atherosclerosis of various localization.
Kovalev YuP ; Dzeranova NYa ; Serova LD; Litmanovich KYu ; Ziskina RA; Rudenko DI
Cor Vasa; 1990; 32(2):118-25. PubMed ID: 2350965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
